DOJ, DDB review anti-drug law

The Department of Justice (DOJ) and the Dangerous Drugs Board (DDB) have initiated an executive review of the Comprehensive Dangerous Drugs Act of 2002 (RA 9165).

This review aligns with President Ferdinand R. Marcos Jr.'s directive for a "whole-of-government" approach to the illegal drugs problem, focusing on both enforcement and rehabilitation.

The agencies aim to incorporate feedback from all stakeholders, including NGOs, civil society groups, the University of the Philippines' Institute of Human Rights, and international partners like the United Nations Office on Drugs and Crimes (UNODC).

DOJ Undersecretary Jesse Hermogenes Andres and DDB Secretary Oscar Valenzuela are leading their respective agencies in this review process.

The review emphasizes multi-faceted interventions that include community-based rehabilitation, education, and reintegration programs alongside law enforcement.

Recommendations and positions from the 1st Drug Policy and Law Reform Summit held in July 2024 will be carefully considered.

The proposed amendments will be evidence-based, supported by data and statistics, and benchmarked against international standards.

Topics in this story

Explore more stories about these topics.

🤖

This story was generated by AI to help you understand the key points. For more detailed coverage, please see the news articles from trusted media outlets below.

News Sources

See how different news organizations are covering this story. Below are the original articles from various Philippine news sources that contributed to this summary.